Moffitt Opens Outpatient Center at Speros

Moffitt Celebrates Grand Opening of Discovery and Innovation Center at Speros

New 250,000-square-foot research facility brings scientists, advanced technology and collaborative spaces together to accelerate cancer discoveries and advance patient care

Pope Leo’s Lung Cancer Diagnosis Highlights Importance of Early Detection

The church leader does not need further treatment after surgery to remove part of his lung

Wife Honors Husband’s Memory at Annual Moffitt Pickleball Tournament

He was in the stands watching her play last year while fighting head and neck cancer

Could a Urine Test Help Detect Breast Cancer Earlier?

New research uses artificial intelligence and electronic sensors to explore a noninvasive approach to breast cancer screening

3 Things You Should Know About Breast Cancer Genetic Risk

Moffitt Cancer Center expert debunks myths about family history and BRCA mutations

New Combination Treatment May Help Slow Advanced Melanoma

Adding HBI-8000 to nivolumab delayed melanoma progression in a phase 3 trial

Moffitt Trial Reports Higher Survival for HER2-Positive Breast Cancer Patients With Leptomeningeal Metastases

The phase 2 trial shows patients treated with radiation therapy followed by two antibodies delivered intrathecally had a median overall survival of 36 months

Personalized Melanoma Vaccine Shows 42% Reduction in Recurrence, Death Risk

New phase 3 findings build on earlier research and offer new hope for patients with high-risk melanoma following surgery

Longtime Moffitt Team Members Reflect on Past 40 Years

With a combined 200 years working at the cancer center, they share their proudest moments and hopes for the future